M&T Bank
NAMS icon

M&T Bank’s NewAmsterdam Pharma NAMS Stock Holding History

M&T Bank’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,328
Closed -$702K – 1630
2024
Q4 		$702K Hold
27,328
– – ﹤0.01% 1036
2024
Q3 		$454K Buy
27,328
+9,593
+54% +$166K ﹤0.01% 1190
2024
Q2 		$341K Buy
17,735
+1,997
+13% +$40.1K ﹤0.01% 1261
2024
Q1 		$372K Buy
+15,738
New +$319K ﹤0.01% 1239

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

M&T Bank's NAMS Position: Q1 2025 in Review

M&T Bank sold out of NewAmsterdam Pharma (NAMS) in Q1 2025, closing a stake of 27,328 shares — an estimated $702K sold.

M&T Bank first reported a position in NAMS in Q1 2024 and held it in 4 quarters. The position peaked at $702K in Q4 2024. 126 funds tracked by Wall St. Rank hold NAMS as of Q1 2025.

  • M&T Bank reported no remaining NewAmsterdam Pharma position as of Q1 2025 after selling out during the quarter.
  • M&T Bank sold 27,328 NewAmsterdam Pharma shares in Q1 2025, an estimated $702K.
  • M&T Bank first reported a position in NewAmsterdam Pharma in Q1 2024 and held it in 4 quarters.
  • M&T Bank's NewAmsterdam Pharma position peaked at $702K in Q4 2024.
  • 126 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q1 2025.

Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.